{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T05:22:43Z","timestamp":1781500963556,"version":"3.54.1"},"reference-count":32,"publisher":"Norwegian Medical Association","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Tidsskriftet"],"published-print":{"date-parts":[[2009]]},"DOI":"10.4045\/tidsskr.08.0084","type":"journal-article","created":{"date-parts":[[2009,5,5]],"date-time":"2009-05-05T07:47:10Z","timestamp":1241509630000},"page":"863-866","source":"Crossref","is-referenced-by-count":5,"title":["Hemokromatose \u2013 fra underdiagnostisert kuriositet til folkesykdom"],"prefix":"10.4045","volume":"129","author":[{"given":"Tor-Arne","family":"Hagve","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arne","family":"\u00c5sberg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rune","family":"Ulvik","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Berit","family":"Borch-Iohnsen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ketil","family":"Thorstensen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2479","reference":[{"key":"1828734_ref_1","doi-asserted-by":"crossref","unstructured":"Jim RT. Unusual test for iron overload. Lancet 1979; 2: 1028.","DOI":"10.1016\/S0140-6736(79)92614-X"},{"key":"1828734_ref_2","doi-asserted-by":"crossref","unstructured":"Milman N, Pedersen P. Evidence that the Cys282Tyr mutation of the HFE gene originated from a population in Southern Scandinavia and spread with the Vikings. Clin Genet 2003; 64: 36\u2009\u2013\u200947.","DOI":"10.1034\/j.1399-0004.2003.00083.x"},{"key":"1828734_ref_3","doi-asserted-by":"crossref","unstructured":"Distante S, Robson KJ, Graham-Campbell J et al. The origin and spread of the HFE-C282Y haemochromatosis mutation. Hum Genet 2004; 115: 269\u2009\u2013\u200979.","DOI":"10.1007\/s00439-004-1152-4"},{"key":"1828734_ref_4","unstructured":"Trousseau A. Glycosurie, diab\u00e8te sucr\u00e9. Clinique M\u00e9dicale de l\u2019Hotel-Dieu de Paris. Paris: Bailli\u00e8re, 1865: 663\u2009\u2013\u200998."},{"key":"1828734_ref_5","unstructured":"von Recklinghausen FD. \u00dcber h\u00e4mochromatose. Tagbl Versamml Natur \u00c4rtze Heidelberg 1889; 62: 324\u2009\u2013\u20095."},{"key":"1828734_ref_6","unstructured":"Sheldon JH. Haemochromatosis. London: Oxford University Press, 1935."},{"key":"1828734_ref_7","unstructured":"Simon M, Pawlotsky Y, Bourel M et al. H\u00e9mochromatose idiopathique: maladie associ\u00e9e a l\u2019antig\u00e9ne tissulaire HLA 3. Nouv Presse M\u00e9d 1975; 19: 1432."},{"key":"1828734_ref_8","doi-asserted-by":"crossref","unstructured":"Feder JN, Gnirke A, Thomas W et al. A novel MHC class-I-like gene is mutated in patients with hereditary hemochromatosis. Nat Genet 1996; 14: 399\u2009\u2013\u2009408.","DOI":"10.1038\/ng0896-399"},{"key":"1828734_ref_9","doi-asserted-by":"crossref","unstructured":"Distante S, Berg JP, Lande K et al. High prevalence of the hemochromatosis-associated Cys282Tyr HFE gene mutation in a healthy Norwegian population in the city of Oslo, and its phenotypic expression. Scand J Gastroenterol 1999; 34; 529\u2009\u2013\u200954.","DOI":"10.1080\/003655299750026290"},{"key":"1828734_ref_10","doi-asserted-by":"crossref","unstructured":"\u00c5sberg A, Hveem K, Thorstensen K et al. Screening for hemochromatosis: high prevalence and low morbidity in an unselected population of 65,238 persons. Scand J Gastroenterol 2001; 36: 1108\u2009\u2013\u200915.","DOI":"10.1080\/003655201750422747"},{"key":"1828734_ref_11","doi-asserted-by":"crossref","unstructured":"Pietrangelo A. Hereditary hemochromatosis. Biochim Biophys Acta 2006; 1763; 700\u2009\u2013\u200910.","DOI":"10.1016\/j.bbamcr.2006.05.013"},{"key":"1828734_ref_12","doi-asserted-by":"crossref","unstructured":"Swinkels DW, Janssen MCH, Bergmans J et al. Hereditary hemochromatosis: genetic complexity and new diagnostic approaches. Clin Chem 2006; 52: 950\u2009\u2013\u200968.","DOI":"10.1373\/clinchem.2006.068684"},{"key":"1828734_ref_13","doi-asserted-by":"crossref","unstructured":"Kemna E, Tjalsma H, Laarakkers C et al. Novel urine hepcidine assay by mass spectrometry. Blood 2005; 106: 3268\u2009\u2013\u200970.","DOI":"10.1182\/blood-2005-05-1873"},{"key":"1828734_ref_14","doi-asserted-by":"crossref","first-page":"858","DOI":"10.4045\/tidsskr.08.0083","volume":"129","author":"Borch-Iohnsen","year":"2009","journal-title":"Tidsskrift for Den norske legeforening"},{"key":"1828734_ref_15","doi-asserted-by":"crossref","unstructured":"\u00c5sberg A, Hveem K, Kr\u00fcger O et al. Persons with screening-detected hemochromatosis: as healthy as the general population? Scand J Gastroenterol 2002; 31: 719\u2009\u2013\u200924.","DOI":"10.1080\/00365520212510"},{"key":"1828734_ref_16","doi-asserted-by":"crossref","unstructured":"Olsson KS, Ritter B, Hansson N et al. The HLA-A1-B8 haplotype hitchhiking with the hemochromatosis mutation: does it affect the phenotype? Eur J\u00a0Haematol 2007; 79: 429\u2009\u2013\u200934.","DOI":"10.1111\/j.1600-0609.2007.00953.x"},{"key":"1828734_ref_17","doi-asserted-by":"crossref","unstructured":"Porto G, Cardoso C, Gordeuk V et al. Clinical and genetic heterogeneity in hereditary haemochromatosis: association between lymphocyte counts and expression of iron overload. Eur J Haematol 2001; 67: 110\u2009\u2013\u20098.","DOI":"10.1034\/j.1600-0609.2001.t01-1-00481.x"},{"key":"1828734_ref_18","doi-asserted-by":"crossref","unstructured":"Lin L, Valore EV, Nemeth E et al. Iron transferrin regulates hepcidin synthesis in primary hepatocyte culture through hemojuvelin and BMP2\/4. Am J\u00a0Hum Genet 2007; 81: 799\u2009\u2013\u2009807.","DOI":"10.1182\/blood-2007-04-087593"},{"key":"1828734_ref_19","doi-asserted-by":"crossref","unstructured":"Adams P, Brissot P, Powell LW. EASL International Concensus Conference on Haemochromatosis. J Hepatol 2000; 33: 485\u2009\u2013\u2009504.","DOI":"10.1016\/S0168-8278(01)80874-6"},{"key":"1828734_ref_20","doi-asserted-by":"crossref","unstructured":"Pietrangelo A. Hereditary hemochromatosis \u2013 a\u00a0new look at an old disease. N Engl J Med 2004; 350: 2383\u2009\u2013\u200997.","DOI":"10.1056\/NEJMra031573"},{"key":"1828734_ref_21","doi-asserted-by":"crossref","unstructured":"\u00c5sberg A, Hveem K, Halvorsen T et al. Prevalence of liver fibrosis and cirrhosis in screening-detected C282Y homozygous subjects. Scand J\u00a0Gastroenterol 2007; 43: 782\u2009\u2013\u20093.","DOI":"10.1080\/00365520601076058"},{"key":"1828734_ref_22","doi-asserted-by":"crossref","unstructured":"Haukeland JW, Lorgen T, Schreiner LT et al. Incidence rates and causes of cirrhosis in a Norwegian population. Scand J Gastroenterol 2007; 42: 1501\u2009\u2013\u20098.","DOI":"10.1080\/00365520701478014"},{"key":"1828734_ref_23","unstructured":"Swinkels DW, Jorna AT, Raymakers RA et al. Synopsis of the Dutch multidisciplinary guideline for the diagnosis and treatment of hereditary haemochromatosis. Netherl J Med 2007; 65: 452\u2009\u2013\u20095."},{"key":"1828734_ref_24","doi-asserted-by":"crossref","unstructured":"Beaton M, Guyader D, Deugnier Y et al. Noninvasive prediction of cirrhosis in C282Y-linked hemochromatosis. Hepatology 2002; 36: 673\u2009\u2013\u20098.","DOI":"10.1053\/jhep.2002.35343"},{"key":"1828734_ref_25","doi-asserted-by":"crossref","unstructured":"Morrison ED, Brandhagen DJ, Phatak PD et al. Serum ferritin level predicts advanced hepatic fibrosis among U.S. patients with phenotypic hemochromatosis. Ann Intern Med 2003; 138: 627\u2009\u2013\u200933.","DOI":"10.7326\/0003-4819-138-8-200304150-00008"},{"key":"1828734_ref_26","doi-asserted-by":"crossref","unstructured":"Willis G, Bardsley V, Fellows IW et al. Hepatocellular carcinoma and the penetrance of HFE C282Y mutations: a cross sectional study. BMC Gastroenterol 2005; 5: 17.","DOI":"10.1186\/1471-230X-5-17"},{"key":"1828734_ref_27","doi-asserted-by":"crossref","unstructured":"Niederau C, Fisher R, P\u00fcrscehl A et al. Long-term survival in patients with hereditary hemochromatosis. Gatroenterology 1996; 110: 1107\u2009\u2013\u200919.","DOI":"10.1053\/gast.1996.v110.pm8613000"},{"key":"1828734_ref_28","doi-asserted-by":"crossref","unstructured":"Brissot P. Diagnosis and current treatments for primary iron overload. Am J Hematol 2007; 82: 1140\u2009\u2013\u20091.","DOI":"10.1002\/ajh.21071"},{"key":"1828734_ref_29","unstructured":"Norsk selskap for hematologi. Handlingsprogram for hemokromatose 2003. www.legeforeningen.no\/asset\/22333\/1\/22333_1.doc (27.2.2009)."},{"key":"1828734_ref_30","doi-asserted-by":"crossref","unstructured":"Adams PC, Barton JC. Haemochromatosis. Lancet 2007; 370: 1855\u2009\u2013\u200970.","DOI":"10.1016\/S0140-6736(07)61782-6"},{"key":"1828734_ref_31","doi-asserted-by":"crossref","unstructured":"\u00c5sberg A. Arvelig hemokromatose \u2013 nytten av screening. Nor J Epidemiol 2006; 16: 23\u2009\u2013\u20098.","DOI":"10.5324\/nje.v16i1.201"},{"key":"1828734_ref_32","doi-asserted-by":"crossref","unstructured":"The U.S. Preventive Task Force. Screening of hemochromatosis: recommendation statement. Ann Intern Med 2006; 145: 204\u2009\u2013\u20098.","DOI":"10.7326\/0003-4819-145-3-200608010-00008"}],"container-title":["Tidsskrift for Den norske legeforening"],"original-title":[],"language":"no","deposited":{"date-parts":[[2023,5,25]],"date-time":"2023-05-25T01:02:11Z","timestamp":1684976531000},"score":1,"resource":{"primary":{"URL":"http:\/\/tidsskriftet.no\/article\/1828734"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009]]},"references-count":32,"journal-issue":{"issue":"9"},"URL":"https:\/\/doi.org\/10.4045\/tidsskr.08.0084","relation":{},"ISSN":["0029-2001"],"issn-type":[{"value":"0029-2001","type":"print"}],"subject":[],"published":{"date-parts":[[2009]]}}}